News

The event will take place on Tuesday from 11 a.m. to 4 p.m. at Joseph P. Riley, Jr. Park, home of the Charleston RiverDogs. Sickle cell anemia disproportionately impacts minority communities ...
Medical advances are changing some of the hallmark physical symptoms of sickle cell disease, columnist Oluwatosin Adesoye ...
The study of genetics heavily relies on the idea that alleles ... are especially important to understand and analyze in terms of chronic diseases, like sickle cell. Sickle cell is a chronic condition ...
For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...
For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.
The Michigan Sickle Cell Data Collection Program has been tracking information from the estimated 4,000 Michigan residents ...
For 21-year-old Javarian Weatherspoon, life without pain feels like a miracle. After growing up with sickle cell disease, he ...
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained ...
WEST MONROE, La. (KTVE/KARD) — Today on Louisiana Living, Ashley Doughty is joined by Lonnikia Robinson to describe the upcoming Walk-A-Thon. For more information, watch the video above ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...